SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-176929
Filing Date
2021-05-28
Accepted
2021-05-28 16:07:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ON FORM S-3 d188388ds3.htm S-3 154962
2 EX-5.1 d188388dex51.htm EX-5.1 7496
3 EX-23.1 d188388dex231.htm EX-23.1 1536
4 GRAPHIC g188388g04r10.jpg GRAPHIC 32743
5 GRAPHIC g188388g0526121410266.jpg GRAPHIC 3993
  Complete submission text file 0001193125-21-176929.txt   212273
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-256614 | Film No.: 21980207
SIC: 2834 Pharmaceutical Preparations